The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration

Journal of Controlled Release

Volumn 171, Issue 2, 2013, Pages 216-224

  Nakamura, Takashi ^a   Yamazaki, Daiki ^a   Yamauchi, Jun ^a   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cancer immunotherapy; Cell penetrating peptide; Liposome; Natural killer T cell

Indexed keywords

ANTIGENS; CYTOLOGY; LIPOSOMES; T-CELLS;

ANTIGEN PRESENTING CELLS; CANCER IMMUNOTHERAPY; CELL-PENETRATING PEPTIDE; CLINICAL APPLICATION; INVERSE CORRELATION; NATURAL KILLER T CELL; SYSTEMIC ADMINISTRATION; THERAPEUTIC EFFECTS;

CELLS;

ALPHA GALACTOSYLCERAMIDE; CD19 ANTIBODY; CD1D ANTIGEN; CELL PENETRATING PEPTIDE; GAMMA INTERFERON; LIPOSOME; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL POPULATION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LASER DOPPLER FLOWMETRY; LIPOSOMAL DELIVERY; LIQUID SCINTILLATION COUNTING; LUNG METASTASIS; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA B16; MOUSE; NANOPHARMACEUTICS; NATURAL KILLER T CELL; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; SPLEEN CELL; THERAPY EFFECT; ZETA POTENTIAL;

ALPHA-GALACTOSYLCERAMIDE (PUBCHEM CID: 2826713); CANCER IMMUNOTHERAPY; CELL PENETRATING PEPTIDE; LIPOSOME; NATURAL KILLER T CELL;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD1D; ANTINEOPLASTIC AGENTS; CELL LINE; CELL LINE, TUMOR; FEMALE; GALACTOSYLCERAMIDES; INTERFERON-GAMMA; LIPOSOMES; LIVER; LUNG; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NANOPARTICLES; NATURAL KILLER T-CELLS; OLIGOPEPTIDES; SPLEEN;

EID: 84881492861     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.07.004     Document Type: Article

References (42)

1. M. Taniguchi, K. Seino, T. Nakayama, The NKT cell system: bridging innate and acquired immunity, Nat Immunol. 4 (2003) 1164-1165. (Pubitemid 37540684)
2. T. Kawano,J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, H. Koseki, M. Taniguchi, CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides, Science 278 (1997) 1626-1629. (Pubitemid 27516282)
3. M. Exley, J. Garcia, S.P. Balk, S. Porcelli, Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8-T cells, J. Exp. Med. 186 (1997) 109-120. (Pubitemid 27304853)
4. V. Cerundolo, J.D. Silk, S.H. Masri, M. Salio, Harnessing invariant NKT cells in vaccination strategies, Nat. Rev. Immunol. 9 (2009) 28-38.
5. E. Kobayashi, K. Motoki, T. Uchida, H. Fukushima, Y. Koezuka, KRN7000, a novel immunomodulator, and its antitumor activities, Oncol. Res. 7 (1995) 529-534. (Pubitemid 26077987)
6. J.A. Berzofsky, M. Terabe, The contrasting roles of NKT cells in tumor immunity, Curr. Mol. Med. 9 (2009) 667-672.
7. J.W. Molling, M. Moreno, H.J. van der Vliet, A.J. van den Eertwegh, R.J. Scheper, B.M. von Blomberg, H.J. Bontkes, Invariant natural killer T cells and immunother-apy of cancer, Clin. Immunol. 129 (2008) 182-194.
8. G. Giaccone, C.J. Punt, Y. Ando, R. Ruijter, N. Nishi, M. Peters, B.M. von Blomberg, R.J. Scheper, H.J. van der Vliet, A.J. van den Eertwegh, M. Roelvink, J. Beijnen, H. Zwierzina, H.M. Pinedo, A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors, Clin. Cancer Res. 8 (2002) 3702-3709. (Pubitemid 35424759)
9. F.L. Schneiders, R.J. Scheper, B.M. von Blomberg, A.M. Woltman, H.L. Janssen, A.J. van den Eertwegh, H.M. Verheul, T.D. de Gruijl, H.J. van der Vliet, Clinical experience with alpha-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection, Clin. Immunol. 140 (2011) 130-141.
10. D.H. Chang, K. Osman, J. Connolly, A. Kukreja, J. Krasovsky, M. Pack, A. Hutchinson, M. Geller, N. Liu, R. Annable, J. Shay, K. Kirchhoff, N. Nishi, Y. Ando, K. Hayashi, H. Hassoun, R.M. Steinman, M.V. Dhodapkar, Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients, J. Exp. Med. 201 (2005) 1503-1517. (Pubitemid 40664093)
11. A. Ishikawa, S. Motohashi, E. Ishikawa, H. Fuchida, K. Higashino, M. Otsuji, T. Iizasa, T. Nakayama, M. Taniguchi, T. Fujisawa, A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer, Clin. Cancer Res. 11 (2005) 1910-1917. (Pubitemid 40471857)
12. S. Motohashi, Y. Okamoto, I. Yoshino, T. Nakayama, Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer, Clin. Immunol. 140 (2011) 167-176.
13. T. Nakamura, R. Moriguchi, K. Kogure, N. Shastri, H. Harashima, Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes, Mol. Ther. 16 (2008) 1507-1514.
14. T. Nakamura, R. Moriguchi, K. Kogure, H. Harashima, Incorporation of polyinosine-polycytidylic acid enhances cytotoxic T cell activity and antitumor effects by octaarginine-modified liposomes encapsulating antigen, but not by octaarginine-modified antigen complex, Int. J. Pharm. 441 (2013) 476-481.
15. T. Komori, T. Nakamura, I. Matsunaga, D. Morita, Y. Hattori, H. Kuwata, N. Fujiwara, K. Hiromatsu, H. Harashima, M. Sugita, A microbial glycolipid functions as a new class of target antigen for delayed-type hypersensitivity, J. Biol. Chem. 286 (2011) 16800-16806.
16. Y. Hattori, I. Matsunaga, T. Komori, T. Urakawa, T. Nakamura, N. Fujiwara, K. Hiromatsu, H. Harashima, M. Sugita, Glycerol monomycolate, a latent tuberculosis-associated mycobacterial lipid, induces eosinophilic hypersensitivity responses in guinea pigs, Biochem. Biophys. Res. Commun. 409 (2011) 304-307.
17. B. Gupta, T.S. Levchenko, V.P. Torchilin, Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides, Adv. Drug Deliv. Rev. 57 (2005) 637-651. (Pubitemid 40255564)
18. S. Futaki, W. Ohashi, T. Suzuki, M. Niwa, S. Tanaka, K. Ueda, H. Harashima, Y. Sugiura, Stearylated arginine-rich peptides: a new class of transfection systems, Bioconjug. Chem. 12 (2001) 1005-1011. (Pubitemid 33136872)
19. I.A. Khalil, K. Kogure, S. Futaki, H. Harashima, High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression, J. Biol. Chem. 281 (2006) 3544-3551. (Pubitemid 43845971)
20. A.C. Benoit, Y. Huang, S. Maneewatchararangsri, P. Tapchaisri, R. Anderson, Regulation of airway eosinophil and neutrophil infiltration by alpha-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease, Vaccine 25 (2007) 7754-7762. (Pubitemid 47588530)
21. Y. Tamura, A. Teng, R. Nozawa, Y. Takamoto-Matsui, Y. Ishii, Characterization of the immature dendritic cells and cytotoxic cells both expanded after activation of invariant NKT cells with alpha-galactosylceramide in vivo, Biochem. Biophys. Res. Commun. 369 (2008) 485-492.
22. E. Macho Fernandez, J. Chang, J. Fontaine, E. Bialecki, F. Rodriguez, E. Werkmeister, V. Krieger, C. Ehret, B. Heurtault, S. Fournel, B. Frisch, D. Betbeder, C. Faveeuw, F. Trottein, Activation of invariant Natural Killer T lymphocytes in response to the alpha-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles, Int. J. Pharm. 423 (2012) 45-54.
23. J.S. Bezbradica, A.K. Stanic, N. Matsuki, H. Bour-Jordan, J.A. Bluestone, J.W. Thomas, D. Unutmaz, L. Van Kaer, S. Joyce, Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo, J. Immunol. 174 (2005) 4696-4705.
24. K. Takara, H. Hatakeyama, G. Kibria, N. Ohga, K. Hida, H. Harashima, Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy, J. Control. Release 162 (2012) 225-232.
25. V.V. Parekh, M.T. Wilson, D. Olivares-Villagomez, A.K. Singh, L. Wu, C.R. Wang, S. Joyce, L. Van Kaer, Glycolipid antigen induces long-term natural killer T cell anergy in mice, J. Clin. Invest. 115 (2005) 2572-2583. (Pubitemid 41266220)
26. G. De Libero, L. Mori, Recognition of lipid antigens by T cells, Nat. Rev. Immunol. 5 (2005) 485-496. (Pubitemid 40835036)
27. A. Homhuan, K. Kogure, H. Akaza, S. Futaki, T. Naka, Y. Fujita, I. Yano, H. Harashima, New packaging method of mycobacterial cell wall using octaarginine-modified liposomes: enhanced uptake by and immunostimulatory activity of dendritic cells, J. Control. Release 120 (2007) 60-69. (Pubitemid 46874617)
28. K. Kogure, R. Moriguchi, K. Sasaki, M. Ueno, S. Futaki, H. Harashima, Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method, J. Control. Release 98 (2004) 317-323. (Pubitemid 38950740)
29. K. Kogure, H. Akita, Y. Yamada, H. Harashima, Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system, Adv. Drug Deliv. Rev. 60 (2008) 559-571. (Pubitemid 351215573)
30. H. Akita, K. Kogure, R. Moriguchi, Y. Nakamura, T. Higashi, T. Nakamura, S. Serada, M. Fujimoto, T. Naka, S. Futaki, H. Harashima, Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation, J. Control. Release 143 (2010) 311-317.
31. R.T. Proffitt, L.E. Williams, C.A. Presant, G.W. Tin, J.A. Uliana, R.C. Gamble, J.D. Baldeschwieler, Liposomal blockade of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles, Science 220 (1983) 502-505. (Pubitemid 13114107)
32. D.M. Underhill, H.S. Goodridge, Information processing during phagocytosis, Nat. Rev. Immunol. 12 (2012) 492-502.
33. C.C. Norbury, Drinking a lot is good for dendritic cells, Immunology 117 (2006) 443-451.
34. F. Ahsan, I.P. Rivas, M.A. Khan, A.I. Torres Suarez, Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages, J. Control. Release 79 (2002) 29-40. (Pubitemid 34164159)
35. J.C. Reece, N.J. Vardaxis, J.A. Marshall, S.M. Crowe, P.U. Cameron, Uptake of HIV and latex particles by fresh and cultured dendritic cells and monocytes, Immunol. Cell Biol. 79 (2001) 255-263. (Pubitemid 32522174)
36. T. Kawano, J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, H. Sato, E. Kondo, M. Harada, H. Koseki, T. Nakayama, Y. Tanaka, M. Taniguchi, Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells, Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 5690-5693. (Pubitemid 28224157)
37. M. Taniguchi, M. Harada, S. Kojo, T. Nakayama, H. Wakao, The regulatory role of Valpha14 NKT cells in innate and acquired immune response, Annu. Rev. Immunol. 21 (2003) 483-513. (Pubitemid 37174539)
38. I. Toura, T. Kawano, Y. Akutsu, T. Nakayama, T. Ochiai, M. Taniguchi, Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide, J. Immunol. 163 (1999) 2387-2391. (Pubitemid 29399156)
39. S. Fujii, K. Shimizu, M. Kronenberg, R.M. Steinman, Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs, Nat. Immunol. 3 (2002) 867-874.
40. I.J. Fidler, Selection of successive tumour lines for metastasis, Nat. New Biol. 242 (1973) 148-149.
41. G. Poste, J. Doll, I.R. Hart, I.J. Fidler, Invitro selection ofmurine B16 melanoma variants with enhanced tissue-invasive properties, Cancer Res. 40 (1980) 1636-1644. (Pubitemid 10102010)
42. T. Ishiguro, M. Nakajima, M. Naito, T. Muto, T. Tsuruo, Identification of genes differentially expressed in B16 murine melanoma sublines with different meta-static potentials, Cancer Res. 56 (1996) 875-879. (Pubitemid 26055480)